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he  major  element  of  1-year  prognosis  in  acute
oronary  syndromes  is  severity  of  initial  clinical
resentation:  Results  from  the  French  MONICA
egistries
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Summary
Background.  —  While  the  death  rate  from  acute  coronary  syndromes  (ACS)  has  been  in  decline
for more  than  50  years,  out-of-hospital  mortality  remains  high  despite  improvements  in  care.
Aim. —  To  evaluate  the  importance  of  out-of-hospital  mortality  and  identify  the  main  predictors
of in-hospital  and  1-year  mortality  in  France.
Methods.  —  Analyses  were  based  on  data  from  the  French  MONICA  population-based  registry,
which included  all  cases  of  ACS  occurring  in  people  aged  35—74  years  during  2006  in  three
geographic  areas  in  France.  We  ﬁrst  evaluated  out-of-hospital  mortality;  then,  using  data  from
patients with  incident  ACS  who  reached  hospital  alive,  Cox  models  were  performed  to  determine
the main  predictors  of  1-year  mortality.  The  number  of  attributable  deaths  was  assessed  for
variables  of  interest.
Results.  —  After  1-year  follow-up,  case-fatality  was  29.3%  for  incident  events  (n  =  2547);  the
proportion  of  out-of-hospital  deaths  was  70.3%,  and  91.5%  of  deaths  occurred  in  the  28  days  fol-
lowing the  ACS.  On  multivariable  analysis,  the  number  of  attributable  deaths  associated  with
three scenarios  (out-of-hospital  life-and-death  emergency,  hospitalization  before  ACS  occur-
rence, and  lack  of  coronary  angiography)  was  130  (accounting  for  59%  of  deaths  occurring  after
reaching  the  hospital)  during  1-year  follow-up.  These  scenarios  corresponded  to  patients  with
an initial  severe  clinical  presentation  in  whom  rates  of  use  of  speciﬁc  treatments  and  invasive
procedures  were  very  low.
Conclusion.  —  A  large  proportion  of  fatalities  after  an  ACS  occurs  in  the  out-of-hospital  phase.
Moreover, the  major  component  of  1-year  mortality  is  associated  with  a  poor  prognosis  at  initial
presentation.  This  ﬁnding  highlights  the  importance  of  cardiovascular  prevention,  population
education  and  better  out-of-hospital  emergency  management  in  improving  prognosis  after  an
ACS.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Rationnel.  —  La  mortalité  des  syndromes  coronariens  aigus  diminue  depuis  50  ans.  La  mortalité
extrahospitalière  reste  élevée  malgré  les  améliorations  de  soins.
Objectif.  —  Évaluer  l’importance  de  la  mortalité  extrahospitalière  et  les  principaux  facteurs
prédictifs  de  la  mortalité  à  un  an  en  France.
Méthodes.  —  Données  de  l’année  2006  des  registres  franc¸ais  MONICA  incluant  exhaustivement
tous les  syndromes  coronariens  aigus  entre  35  et  74  ans  dans  trois  bassins  géographiques.  La
mortalité  extrahospitalière  a  été  évaluée,  les  facteurs  prédictifs  de  la  mortalité  à  un  an  des  SCA
inauguraux  hospitalisés  ont  été  analysés  par  modèles  de  Cox.  Le  nombre  de  décès  attribuables
a ensuite  été  calculé  pour  des  variables  d’intérêt.
Résultats.  — La  létalité  à  un  an  des  2547  épisodes  inauguraux  était  de  29,3  %.  La  propor-
tion de  décès  extrahospitaliers  était  de  70,3  %  ;  91,5  %  des  décès  survenant  dans  les  28  jours
suivant l’hospitalisation.  Le  nombre  de  décès  attribuables  à  trois  situations  identiﬁées  à  partir
de l’analyse  multivariée  (menaces  vitales  pré-hospitalières,  sujets  déjà  hospitalisés  et  patients
sans coronarographie)  était  de  130  à  un  an,  soit  59  %  des  décès  survenant  chez  les  sujets  arrivés
vivants à  l’hôpital.  Ces  situations  correspondaient  à  des  patients  déjà  très  graves  initialement
et ne  bénéﬁciant  pas  des  traitements  habituels.
Conclusion.  — La  majorité  des  décès  surviennent  à  la  phase  pré-hospitalière.  De  plus,  la
majorité des  décès  à  un  an  est  associée  à  un  tableau  déjà  grave  avant  la  médicalisation.  Cela
démontre  l’importance  de  la  prévention,  de  l’éducation  de  la  population  et  d’une  amélioration
de la  prise  en  charge  pré-hospitalière.
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Introduction
Management  of  acute  coronary  syndromes  (ACS)  has
improved  greatly  over  the  past  few  decades,  with  impor-
tant  consequences  in  terms  of  the  epidemiology  of  coronary
heart  disease.  Mortality  is  determined  by  incidence  (incident
events  or  recurrences)  and  by  lethality  (at  the  acute  phase
and  over  the  long  term).  The  mortality  rate  after  an  ACS  has
been  in  decline  for  more  than  50  years  throughout  the  world,
w
r
d
os  droits  réservés.
ut  some  geographic  differences  have  been  reported  [1—4].
n  the  United  States,  the  rate  of  death  from  coronary  heart
isease  decreased  by  59%  between  1950  and  1999  [5].  This
mprovement  was  associated  primarily  with  a  decrease  in
he  case-fatality  of  acute  events,  and  in  a  more  inconsistent
ay  with  a  decrease  in  incidence  of  ACS  [6—12]. However,
ecent  data  from  France  suggest  that  overall  mortality  has
ecreased  slowly,  mainly  due  to  a decrease  in  incidence
f  coronary  heart  disease,  whereas  short-term  case-fatality
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digure 1. Distribution of deaths in the entire cohort (4220 ACS). 
ppears  to  have  plateaued  [13]. This  pattern  may  reﬂect  the
mpact  of  deaths  occurring  outside  of  hospital  [6,14—16],
hich  appear  to  be  almost  non-modiﬁable.
The  aim  of  our  study  was  ﬁrst  to  estimate  and  describe
he  distribution  of  in-hospital  and  out-of  hospital  deaths
ollowing  ACS  in  a  population-based  registry,  and  then  to
dentify  the  main  predictors  of  mortality  occurring  during
he  out-of-hospital  phase,  and  post-discharge  up  to  1  year.
ethods
opulation and registry
ur  work  was  based  on  2006  data  from  the  French  MONICA
egistries,  in  which  information  was  collected  in  all  cases  of
CS  occurring  in  people  aged  35—74  years  in  three  areas  in
orth,  North-East  and  South-West  France.  These  exhaustive,
opulation-based  registries  collected  data  from  the  case
les  of  all  patients  hospitalized  for  an  ACS  (multiple  sources
ere  cross-checked),  but  also  from  all  patients  who  died
ut-of-hospital  from  a  suspected  ACS,  in  which  case  the  gen-
ral  practitioner  or  the  physician  who  notiﬁed  the  death  was
nterviewed  [1—4]. Out-of-hospital  deaths  corresponded  to
atients  dying  after  an  out-of-hospital  ACS  diagnosis  (ﬁve  of
he  incident  events),  those  dying  after  symptoms  suggestive
f  an  ACS  (67  of  the  incident  events),  sudden  deaths  occur-
ing  within  24  hours  of  the  index  event  (422  of  the  incident
t
u
(acute coronary syndrome.
vents),  and  other  deaths  with  insufﬁcient  data  but  with-
ut  any  other  suspected  cause  or  medical  history  (30  of  the
ncident  events).
We  ﬁrst  analysed  the  data  collected  over  1  year  from  4220
CS  patients  to  estimate  and  describe  the  distribution  of  in-
ospital  and  out-of  hospital  mortality.  We  then  conducted
n  analysis  to  identify  predictors  of  1-year  mortality  using
ata  from  the  2023  patients  with  an  incident  event  who
eached  hospital  alive  (Fig.  1).  The  rate  of  complete  follow-
p  (follow-up  to  ≥  1  year  or  death  during  follow-up)  among
hese  2023  patients  was  95.9%.
eterminants and outcomes
he  main  outcome  was  mortality  at  1  year  after  the  index
vent.  Out-of-hospital  deaths  were  recorded  from  the
atient’s  medical  history,  but  only  age,  gender  and  previous
oronary  heart  disease  were  recorded  for  those  who  died
efore  reaching  the  hospital.
More  data  were  collected  for  hospitalized  patients,
ncluding  age,  gender  and  chronic  treatments  for  cardio-
ascular  diseases  (anticoagulants,  medications  for  diabetes,
ntihypertensive  drugs,  lipid-lowering  drugs,  antiarrhythmic
rugs  and  antiplatelets).The  type  of  ACS  was  determined  by  troponin  concentra-
ion  and  electrocardiographic  data,  and  was  categorized  as
nstable  angina  or  non-ST-elevation  myocardial  infarction
UA/NSTEMI),  ST-elevation  myocardial  infarction  (STEMI)
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2One-year  prognosis  and  severity  of  ACS  in  France  
and  unclassiﬁed  (non-interpretable  electrocardiogram;  cor-
responding  to  4%  of  cases).  Early  complications  were
described  as  acute  heart  failure  (dyspnoea,  acute  pul-
monary  oedema  and  out-of-hospital  diuretic  use)  and
life-threatening  complications  (resuscitated  cardiac  arrests,
shocks  and  out-of-hospital  use  of  amines).  Life-threatening
complications  were  divided  into  those  occurring  out-of-
hospital  (associated  with  out-of-hospital  explicit  treatments
for  cardiac  arrest  or  shock:  xylocaine,  amines,  sodium
bicarbonate  or  external  electrical  deﬁbrillation)  and  those
occurring  in  hospital  (all  others;  deﬁned  only  for  patients
reaching  the  hospital  alive).  Coronary  anatomical  status  was
categorized  as  one-vessel  disease,  multivessel  disease,  left
main  coronary  artery  lesion  and  unknown.
Out-of-hospital  management  was  described  in  terms  of
delays  between  symptom  onset  and  hospitalization  (patients
already  hospitalized  before  the  event  were  considered  as  a
speciﬁc  category),  management  in  a  mobile  intensive  care
unit  and  out-of-hospital  speciﬁc  treatment  (e.g.  aspirin,
clopidogrel  or  anticoagulant).
In-hospital  management  was  described  in  terms  of
prescription  of  recommended  treatments  (these  were  com-
bined  into  a  single  variable  corresponding  to  the  prescription
of  dual  antiplatelet  therapy,  anticoagulants,  beta-blockers,
statins  and  angiotensin-converting  enzyme  [ACE]  inhibitors),
and  by  revascularization  strategy  (no  invasive  exploration,
coronary  angiography  without  revascularization,  percuta-
neous  coronary  intervention  [PCI]  and  coronary  artery
bypass  graft  [CABG]).
Statistical analyses
The  overall  population  was  described  according  to  case-
fatality,  corresponding  to  the  proportion  of  deaths  in  the
study  groups  (4220  incident  and  recurrent  cases  of  ACS;  2547
incident  ACS  and  2023  incident  hospitalized  ACS).  Cox  mod-
elling  was  then  use  to  identify  predictors  of  1-year  mortality.
Before  introducing  covariates  in  the  model,  the  assump-
tion  of  proportional  risk  was  checked  for  all  variables  and
log-linearity  was  assessed  for  quantitative  variables.  Missing
data  for  both  the  type  of  ACS  and  the  delay  to  hospital-
ization  were  analysed  as  a  speciﬁc  category  because  they
were  more  frequent,  but  for  all  other  missing  data  were
switched  to  a  negative  response.  Sensitivity  analyses  were
performed,  replacing  missing  data  with  positive  responses.
Predictors  of  1-year  mortality  were  identiﬁed  by  creating
a  model  of  causation  in  which  explanatory  covariates  were
introduced  successively  and  considered  in  the  model  accord-
ing  to  their  distance  from  the  outcome  variable  (1-year
mortality).  More  precisely,  variables  considered  as  the  most
distant  from  the  outcome  were  ﬁrst  analysed  (age,  gender
and  previous  medical  treatments).  Then,  intermediate  and
proximal  explanatory  variables  were  added  to  the  model  in
the  following  order:  hospitalization  before  ACS  occurrence,
type  of  ACS,  early  complications,  out-of-hospital  manage-
ment  and  in-hospital  management  and  complications.  This
approach  is  more  appropriate  than  stepwise  regression  to
study  determinants  that  are  not  equally  distant  to  the  out-
come  in  the  causal  chain.  This  process  was  inspired  by  that
used  more  frequently  in  social  epidemiology  [17]. Variables
interpreted  as  clinically  signiﬁcant  markers  of  severity  of
o
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h
(igure 2. Chronological distribution of deaths (2547 incident
CS). ACS: acute coronary syndrome.
nitial  presentation  and  with  a  strong  statistical  weight  were
nalysed  in  greater  detail.
The  different  subgroups  are  described  using  counts  and
ercentages  or  as  medians.  The  2 test  or  Fisher’s  exact  test
ere  used  to  test  for  differences  in  qualitative  variables  and
tudent’s  t  test  or  the  Mann-Whitney  test  for  differences  in
uantitative  variables.
We  calculated  the  number  of  attributable  deaths  for
ach  variable  of  interest  with  a  similar  method  used  for
stimating  attributable  risk  [18]. Variables  of  interest  were
onsidered  as  the  ‘exposure’,  and  death  was  considered  as
he  ‘disease’.  The  population-attributable  fraction  for  each
xposure  was  estimated  as:
p × (adjusted  Hazard  ratio  −  1) /adjusted  Hazard  ratio
where  p  was  the  proportion  of  patients  with  the  exposure
mong  death  cases  and  where  the  adjusted  hazard  ratio  was
erived  from  the  Cox-adjusted  estimate  related  to  the  vari-
ble  of  interest  [19]. The  number  of  attributable  deaths  was
hen  calculated  by  multiplying  the  population-attributable
raction  by  the  total  number  of  deaths.  Conﬁdence  inter-
als  (95%  CI)  for  population-attributable  fractions  were
alculated  using  the  Greenland  formula  [20]. An  overall
opulation-attributable  fraction  was  also  estimated,  repre-
enting  the  joint  impact  of  the  variables  of  interest.  For
alculating  the  overall  population-attributable  fraction,  a
ingle  exposed  level  was  considered  and  was  deﬁned  as
xposure  to  at  least  one  variable  of  interest.  The  reference
evel  was  deﬁned  as  exposure  to  none  of  the  variables  of
nterest.
esults
ut-of-hospital and in-hospital case-fatality
he  different  episodes  of  mortality  are  presented  in
igs.  1  and  2.  Among  the  total  population,  the  overall
8-day  case-fatality  was  32.7%  (1381/4220).  Of  the  1028
ut-of-hospital  deaths  (accounting  for  74.4%  of  28-day  case-
atality),  51.0%  were  incident  events,  17.9%  had  a  coronary
istory  and  31.1%  had  missing  data  for  medical  history.  Most
84.3%)  out-of-hospital  deaths  occurred  at  home.
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Among  the  2547  patients  with  incident  ACS,  524  (20.6%)
ied  before  reaching  the  hospital,  158  (6.2%)  died  in  the  ﬁrst
8  days,  and  63  (2.5%)  died  between  28  days  and  1  year  after
he  event.  Total  1-year  mortality  was  29.3%,  the  proportion
f  out-of-hospital  deaths  was  70.3%,  and  91.5%  of  deaths
ccurred  in  the  28  days  following  the  ACS.
Among  the  2023  hospitalized  patients  with  incident  ACS,
21  (10.9%)  died  in  the  ﬁrst  year:  76  in  the  ﬁrst  24  hours,  82
etween  24  hours  and  28  days,  and  63  between  28  days  and
 year  (the  28-day  case-fatality  rate  was  7.8%  for  people
eaching  the  hospital  alive).
Among  the  1157  hospitalized  ACS  patients  with  previ-
us  coronary  heart  disease  (184  out-of-hospital  deaths  were
xcluded),  96  died  in  the  ﬁrst  24  hours  and  89  between
4  hours  and  28  days  (28-day  case-fatality  was  16.0%  for  peo-
le  reaching  the  hospital  alive).
urvival analyses in incident ACS patients
eaching the hospital alive
he  characteristics  of  the  2023  patients  with  an  incident  ACS
ho  reached  the  hospital  alive,  along  with  univariate  asso-
iations  with  1-year  mortality,  are  shown  in  Table  1.  Factors
ssociated  with  1-year  mortality  in  this  population  are  shown
n  Table  2.
ariables of  interest: initial severity of ACS
hree  variables  of  interest  (out-of-hospital  life-and-death
mergency,  hospitalization  before  ACS  occurrence,  and  lack
f  coronary  angiography)  were  interpreted  as  determi-
ants  or  proxy  variables  of  the  initial  severity  of  the  ACS.
mong  the  2023  patients,  99  (4.9%)  presented  with  an
ut-of-hospital  life-and-death  emergency,  56  of  who  died
case-fatality  56.6%);  120  subjects  were  already  hospital-
zed  (5.9%),  of  which  56  died  (case-fatality  46.7%);  and  187
ubjects  (9.2%)  did  not  have  invasive  coronary  explorations,
f  which  119  died  (case-fatality  63.6%).  Among  these  187
ubjects,  95  were  not  associated  with  an  out-of-hospital
mergency  and  were  not  already  hospitalized,  43  of  who
ied.  The  description  of  these  variables  is  presented  in
able  3.
umber of attributable deaths
he  number  of  deaths  attributable  to  each  variable  of  inter-
st  was  estimated  for  the  2023  incident  ACS  who  reached  the
ospital  alive  (Table  4).  While  none  of  the  patients  could
elong  simultaneously  to  the  group  already  hospitalized
nd  to  those  with  an  out-of-hospital  life-and-death  emer-
ency,  some  patients  who  had  not  had  a  coronary  exploration
ould  be  included  in  these  two  subgroups;  consequently,  only
atients  who  did  not  belong  to  both  groups  were  analysed
95  patients,  43  deaths),  which  would  probably  underesti-
ate  the  number  of  attributable  deaths.
The  total  number  of  deaths  attributable  to  the  three
ariables  of  interest  was  130  (95%  CI  86—170)  after  adjust-
ent  for  potential  confounding  factors,  corresponding  to
9%  (95%  CI  39—77)  of  1-year  mortality  (221  deaths)  after
xclusion  of  out-of-hospital  deaths.  The  adjusted  number  of
ttributable  deaths  was  135  (95%  CI  113—152)  when  consid-
ring  the  three  groups  as  one  variable,  conﬁrming  good
o
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tability  of  the  estimation  (adjusted  hazard  ratio  7.68;
opulation-attributable  fraction  0.61,  95%  CI  0.51—0.69).
The  same  analyses  were  performed  through  logistic
egression  for  28-day  mortality.  Of  the  158  deaths  over  this
eriod,  115  (95%  CI  73—152)  of  the  127  with  an  exposure
ere  attributable  to  the  three  categories  (73%  of  deaths,
5%  CI  46—96).
ensitivity analyses
he  number  of  attributable  deaths  was  estimated  after
eplacing  missing  data  with  the  positive  response.  The
esults  did  not  differ  signiﬁcantly  but  the  number  of
ttributable  deaths  increased  slightly.  Stratiﬁed  analyses
n  hospitalization  before  ACS  occurrence  or  adjustment  for
ospital  discharge  treatments  (through  a  similar  composite
ariable  as  that  described  for  in-hospital  treatments)  did  not
odify  the  results  signiﬁcantly.
iscussion
he  exhaustiveness  of  this  population-based  registry,  includ-
ng  description  of  the  out-of-hospital  period  and  long-term
ollow-up,  allows  a  complete  evaluation  of  the  current  epi-
emiology  of  ACS.  Coronary  heart  disease  remains  a  serious
ondition,  with  an  overall  28-day  case-fatality  rate  of  32.7%
nd  with  three-quarters  of  people  dying  before  reaching
ospital.  Patients  who  died  out-of-hospital  were  younger
han  those  who  died  in  the  28  days  after  reaching  the  hos-
ital  (61  and  68  years,  respectively,  P  <  0.0001),  but  were
he  same  age  as  survivors  at  28  days  (61  years).  A  large
ercentage  of  out-of-hospital  deaths  (51%)  occurred  with
ncident  events.  Among  individuals  with  incident  ACS,  76.8%
f  the  deaths  occurring  within  28  days  happened  out  of  hos-
ital,  and  70.3%  of  deaths  at  1  year  were  out  of  hospital.
hese  data  are  similar  to  those  reported  previously  in  other
ountries  [6,14—16].
While  our  registry  is  exhaustive,  with  standardized  meth-
ds  used  for  patient  inclusion,  the  study  of  out-of-hospital
eaths  is  difﬁcult  [21,22]  because  of  uncertain  diagnoses.
ur  registry  encompasses  a relatively  young  population,
ith  a  limited  number  of  very  old  patients  and/or  indi-
iduals  with  severe  co-morbidities.  Indeed,  the  majority  of
udden  deaths  are  of  cardiac  origin,  with  most  being  coro-
ary  deaths  in  young  people  [23,24].  Authors  also  separate
udden  deaths  that  are  genuinely  related  to  an  ACS  from
electrical’  coronary  deaths  promoted  by  a  former  myocar-
ial  ischaemic  scar,  which  occur  frequently  without  any
revious  alerting  symptom  [25—28]. This  is  one  reason  why
e  studied  only  incident  events  for  most  of  the  analyses.
ndeed,  even  if  a  death  is  associated  with  an  ‘electrical’
udden  death  without  real  ACS,  it  remains  the  ﬁrst  clinical
anifestation  of  coronary  heart  disease.  ‘Electrical’  sudden
eaths  occurring  in  people  with  previous  known  coronary
eart  diseases  depend  more  on  secondary  prevention.
The  rate  of  1-year  mortality  with  hospitalized  incident
vents  was  10.9%,  which  is  lower  than  that  described  in
ther  French  ACS  registries  such  as  FAST-MI  2005  (11.3%
or  NSTEMI  and  15.2%  for  STEMI)  (FAST-MI  Investigators.
ersonal  communication).  This  is  easily  explained  by  differ-
nces  in  the  populations  (less  than  75  years  of  age,  inclusion
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Table  1  Characteristics  of  the  cohort  and  univariate  associations  with  1-year  mortality  (2023  hospitalized  incident  acute
coronary  syndromes).
Proportion  (%)  Hazard  ratioa 95%  CI  P
Centre
Toulouse 31.1 1.00
Strasbourg 36.8 1.82  1.25—2.66 0.002
Lille  32.1  2.47  1.71—3.58  <  0.0001
Age  58  (17)b 1.05c 1.03—1.06  <  0.0001
Female  gender  23.7  1.19  0.88—1.60  0.25
Previous  treatments
Anticoagulants  4.1  3.50  2.32—5.26  <  0.0001
Antidiabetic  medication  15.0  1.66  1.21—2.28  0.002
Antihypertensive  drugs 37.6  1.46  1.12—1.90  0.005
Lipid-lowering  agents  22.3  0.79  0.56—1.11  0.17
Antiplatelet  therapy  13.1  1.69  1.21—2.35  0.002
Antiarrhythmic  drugs  2.4  2.28  1.24—4.18  0.008
Type  of  ACS
STEMI  (without  thrombolysis)  42.0  1.00
STEMI  (with  thrombolysis)  9.3  0.35  0.16—0.75  0.007
UA/NSTEMI  44.7  0.83  0.61—1.13  0.24
Unclassiﬁable  4.0  8.55  5.98—12.23  <  0.0001
Out-of-hospital  life-and-death  emergency  4.9  9.55  7.03—12.98  <  0.0001
Acute  heart  failure  15.5  3.09  2.34—4.07  <  0.0001
Delay  until  hospitalization
≥ 2  hours  65.6  1.00
<  2  hours  21.6  2.44  1.75—3.39  <  0.0001
Already  hospitalized  5.9  9.80  6.96—13.80  <  0.0001
Unknown  6.9  2.73  1.70—4.37  <  0.0001
Transfer  with  medical  mobile  unit  42.5  1.15  0.88—1.50  0.30
Out-of-hospital  speciﬁc  treatment 32.6  0.32  0.22—0.47  <  0.0001
In-hospital  life-and-death  emergency 4.8 8.97  6.58—12.22  <  0.0001
In-hospital  recommended  treatments 50.1  0.17  0.12—0.25  <  0.0001
Revascularization
PCI 66.6 1.00
No  exploration 9.2 18.81  13.98—25.31  <  0.0001
Angiography  without  PCI 20.2 1.20  0.77—1.89  0.42
CABG 4.0 0.92  0.34—2.52  0.88
Coronary  status
One-vessel  disease  48.8  1.00
Multivessel  disease  40.1  1.39  0.93—2.08  0.11
Left  main  coronary  artery  1.7  4.29  1.83—10.06  0.001
Unknown/No  exploration  9.4  21.19  14.98—29.95  <  0.0001
95% CI: 95% conﬁdence interval; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; STEMI: ST-elevation
myocardial infarction; UA/NSTEMI: non-ST-elevation myocardial infarction.
a Hazard ratio for 1-year mortality, estimated by Cox modelling.
b Median in years (interquartile range).
c For a 1-year increase.
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fof  unstable  angina,  exclusion  of  recurrences).  Indeed,  our
population  was  relatively  young,  with  ages  ranging  from  35
to  74  years  (median  58),  and  with  a  majority  of  men  as  is  usu-
ally  described  for  patients  with  coronary  heart  disease.  Age
was  associated  with  an  increased  mortality  but  no  signiﬁcant
relationship  was  observed  for  gender  in  this  young  popula-
tion.  In  hospitalized  incident  events,  15.0%  were  already  on
treatments  for  diabetes,  4.1%  on  anticoagulant  treatments
and  37.6%  on  antihypertensive  drugs.  Previous  chronic  use  of
anticoagulant  treatments  was  associated  with  a  signiﬁcantly
o
aigher  mortality  (and  there  was  a trend  associated  with
he  use  of  medications  for  diabetes).  On  the  other  hand,
revious  use  of  lipid-lowering  drugs  was  associated  with  a
igniﬁcantly  decreased  mortality  after  adjustment  for  age.
ubjects  already  hospitalized  before  the  event  (5.9%)  had
 poor  prognosis  (adjusted  hazard  ratio  for  1-year  case-
atality  4.66,  P  <  0.0001).There  was  no  signiﬁcant  impact  of  the  type  of  ACS
n  1-year  mortality,  but  unclassiﬁable  events  were  associ-
ted  with  an  increased  mortality,  probably  corresponding
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Table  2  Multivariable  analysis  assessing  predictive  factors  for  1-year-mortality  (2023  hospitalized  incident  acute  coro-
nary  syndromes).
Hazard  ratioa 95%  CI P
Ageb 1.04  1.03—1.06  <  0.0001
Female  genderb 0.92  0.68—1.25  0.59
Previous  treatmentsb
Anticoagulants  2.56  1.64—4.02  <  0.0001
Antidiabetic  medication  1.36  0.97—1.89  0.073
Antihypertensive  drugs 0.98  0.72—1.33  0.89
Lipid-lowering  agents 0.57  0.40—0.82  0.002
Antiplatelet  therapy 1.25  0.88—1.77 0.22
Antiarrhythmic  drugs 1.08  0.56—2.06 0.83
Hospitalization  before  ACS  occurrenceb 4.66  3.31—6.56 <  0.0001
Type  of  ACSc
STEMI  1.00
UA/NSTEMI 0.84  0.62—1.14  0.27
Unclassiﬁable 5.13  3.44—7.63  <  0.0001
Out-of-hospital  life-and-death  emergencyd 13.68  9.77—19.15  <  0.0001
Acute  heart  failuree 1.87  1.40—2.52  <  0.0001
Delay  until  hospitalizationf
≥  2  h 1.00
<  2  h 1.53 1.07—2.20  0.020
Unknown 2.01  1.22—3.33  0.006
Transfer  with  medical  mobile  unitf 1.15  0.79—1.68  0.47
STEMI  with/without  thrombolyticg 0.64  0.28—1.42  0.27
Out-of-hospital  speciﬁc  treatmentg 0.29  0.18—0.45  <  0.0001
In-hospital  life-and-death  emergencyg 5.92  4.07—8.59  <  0.0001
In-hospital  recommended  treatmentsh 0.28  0.19—0.42  <  0.0001
Revascularization i
PCI 1.00
No  exploration 3.63  2.36—5.59  <  0.0001
Angiography  alone 0.90  0.56—1.45  0.66
CABG 0.95  0.34—2.64 0.92
95% CI: 95% conﬁdence interval; ACS: acute coronary syndrome; CABG: coronary artery bypass graft; PCI: percutaneous coronary
intervention; STEMI: ST-elevation myocardial infarction; UA/NSTEMI: non-ST-elevation myocardial infarction.
a Hazard ratio for 1-year mortality, estimated by Cox modelling.
b Adjusted for centre, age, gender and previous treatments.
c Adjusted for b and hospitalization before ACS occurrence.
d Adjusted for c and type of ACS.
e Adjusted for d and out-of-hospital life-and-death emergency.
f Adjusted for e, acute heart failure, delay until hospitalization and transfer with medical mobile unit.
g Adjusted for f and out-of-hospital speciﬁc treatments and thrombolytic therapy.
h Adjusted for g and in-hospital life-and-death emergency.
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o  early  deaths.  The  majority  of  subjects  (51.3%)  had
TEMI,  although  recent  data  [29]  have  shown  a  greater
roportion  of  UA/NSTEMI  versus  STEMI  in  ACS.  This  dis-
repancy  could  be  explained  by  the  young  age  of  the
opulation  and  the  restriction  to  incident  events.  Out-of-
ospital  life-and-death  emergencies  were  associated  with
n  important  increase  in  mortality  (adjusted  hazard  ratio
3.68,  P  <  0.0001),  while  acute  heart  failure  seemed  to  have
 less  strong  impact  but  was  still  signiﬁcant.  In-hospital  life-
nd-death  emergencies  were  associated  with  a  signiﬁcant
ut  less  important  increase  in  mortality.
Concerning  the  out-of-hospital  and  in-hospital  manage-
ent,  delays  to  hospitalization  were  mainly  greater  than
 hours  and  less  than  the  half  of  the  cases  were  managed  by
e
a
r
t mobile  intensive  care  unit.  Surprisingly,  a  shorter  delay
etween  symptom  onset  and  hospitalization  was  associ-
ted  with  a  poorer  prognosis  and  there  was  no  impact  of
obile  intensive  care  units  on  mortality  rates.  This  can
robably  be  explained  by  confounding  biases,  with  the  most
ritical  patients  being  managed  earlier  and  being  more  med-
calized.  Out-of-hospital  and  in-hospital  speciﬁc  treatments
ere  associated  with  decreased  mortality.
More  than  90%  of  patients  had  a  coronary  angiography,
6.6%  with  PCI  and  4.0%  with  CABG.  We  did  not  detect  any
ffect  of  revascularization  (PCI  or  CABG)  on  mortality  in  our
nalyses,  probably  because  most  of  the  subjects  underwent
evascularization,  leading  to  a  very  homogeneous  popula-
ion.  However,  people  who  did  not  beneﬁt  from  a  coronary
One-year  prognosis  and  severity  of  ACS  in  France  485
Table  3  Description  of  three  selected  variables  of  interest  (2023  incident  hospitalized  ACS  population).
Out-of-hospital
life-and-death
emergency  (n  =  99)
Hospitalization  before
ACS  occurrence
(n  =  120)
No  coronary
angiography  (n  =  187)
Yes No P Yes No P  Yes  No  P
Age  (median  in  years)  57.0  58.0  0.55  66.0  58.0  <  0.0001  66.0  58.0  <  0.0001
Female  gender 24.2  23.7  0.90  40.8  22.6  <  0.0001  31.0  23.0  0.014
Previous  treatments
Anticoagulants 4.0  4.1  1.00 18.3  3.2  <  0.0001  14.4  3.1  <  0.0001
Antidiabetic 10.1  15.2  0.16 24.2  14.4  0.004  20.3  14.4  0.032
Antihypertensive
drugs
36.4  37.6  0.80 53.3  36.6  <  0.0001 46.0  36.7  0.013
Lipid-lowering  agents  19.2  22.5  0.45  15.0  22.8  0.048  19.8  22.5  0.39
Antiplatelet  therapy  12.1  13.1  0.77  26.7  12.2  <  0.0001  23.0  12.1  <  0.0001
Antiarrhythmic  drugs  5.1  2.3  0.088  5.8  2.2  0.023  4.8  2.2  0.040
Type  of  ACS
STEMI  62.6  50.7  <  0.0001  32.5  52.5  <  0.0001  26.2  53.9  <0.0001
UA/NSTEMI  28.3  45.6  44.2  44.8  49.7  44.2
Unclassiﬁable  9.1  3.7  23.3  2.7  24.1  1.9
Resuscitated  cardiac
arrest
79.8 2.3  <  0.0001  10.8  5.8  0.027  24.6  4.2  <  0.0001
Shock  22.2  3.6  <  0.0001  21.7  3.5  <  0.0001  25.7  2.4  <  0.0001
Premature  heart  failure 29.3  14.8  <  0.0001  26.7  14.8  <  0.0001  35.8  13.4  <  0.0001
Delay  until
hospitalization
≥  2  h 42.4 66.8  <  0.0001 0.0  69.7  <  0.0001  31.6  69.1  <  0.0001
<  2  h 53.5 20.0  0.0  23.0  26.2  21.1
Already  hospitalized 0.0  6.2  100.0  0.0  30.5  3.4
Unknown 4.0  7.0  0.0  7.3  11.8  6.4
Transfer  with  medical
mobile  unit
97.0 39.7  <  0.0001 0.0  45.2  <  0.0001  38.5  42.9  0.24
Out-of-hospital  speciﬁc
treatment
41.4 32.2  0.056  0.0  34.7  <  0.0001  8.0  35.1  <  0.0001
In-hospital
recommended
treatments
26.3  51.3  <  0.0001  24.2  51.7  <  0.0001  9.6  54.2  <0.0001
Revascularization
PCI  52.5  67.3  <  0.0001  25.0  69.2  <  0.0001  0.0  73.4  <  0.0001
No  exploration  35.4  7.9  47.5  6.8  100.0  0.0
Angiography  without
PCI
9.1  20.7  26.7  19.8  0.0  22.2
CABG  3.0  4.1  0.8  4.2  0.0  4.4
Data given as number (%) unless otherwise stated.
CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; STEMI: ST-elevation myocardial infarction; UA/NSTEMI:
d
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angiography  had  a  signiﬁcant  increased  mortality  (adjusted
hazard  ratio  3.63,  P  <  0.0001);  this  appears  largely  due  to  the
fact  that  people  who  were  not  explored  were  those  with  a
more  severe  clinical  presentation.  Left  main  coronary  artery
lesion  was  also  associated  with  a  poor  prognosis.
Predictors of outcomeAfter  multivariable  analysis,  three  situations  were  iden-
tiﬁed  that  were  strongly  associated  with  poor  outcome:
hospitalization  before  ACS  occurrence  (120  patients,  56
h
g
aeaths);  presence  of  an  out-of-hospital  life-and-death
mergency  (99  patients,  56  deaths);  and  lack  coronary
xploration  following  the  ACS  (187  patients,  119  deaths).
hese  three  situations  represented  less  than  one-sixth  of
he  2023  incident  hospitalized  ACS  events,  but  60%  of  1-year
eaths  (130  deaths  attributable  to  these  three  situations).
hen  analysing  28-day  mortality,  115  deaths  (72.8%)  were
ttributable  to  these  three  situations.There  were  no  differences  in  age,  gender  or  medical
istory  associated  with  out-of-hospital  life-and-death  emer-
ency,  but  a  signiﬁcantly  higher  rate  of  STEMI  was  observed
mong  emergent  patients.  These  situations  mainly  included
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Table  4  Estimation  of  the  number  of  deaths  attributable  to  selected  variables  of  interest,  during  the  1-year  follow-up
(2023  hospitalized  incident  acute  coronary  syndromes).
Hazard  ratio
[95%  CI]
Number  of
exposed
deaths
Population-
attributable
fraction
Number  of
attributable
deaths
Hospitalization  before  the  ACS  occurrence  (n  =  120)a
Unadjusted  6.79
[5.01—9.21]
56 0.22
[0.15—0.27]
48
[34—61]
Adjustedb 4.66
[3.31—6.56]
56 0.20
[0.13—0.26]
44
[29—58]
Out-of-hospital  life-and-death  emergency  (n  =  99)a
Unadjusted  9.55
[7.03—12.98]
56 0.23
[0.17—0.28]
50
[36—63]
Adjustedc 13.68
[9.77—19.15]
56 0.24
[0.17—0.29]
52
[38—65]
No  coronary  angiography  (n  =  95)a
Unadjusted  5.96
[4.27—8.33]
43 0.16
[0.11—0.21]
36
[23—47]
Adjustedd 4.87
[3.13—7.58]
43 0.16
[0.09—0.22]
34
[20—48]
Total  (n  =  314)a
Unadjusted 155 0.61
[0.42—0.77]
134
[94—171]
Adjusted 155 0.59
[0.39—0.77]
130
[86—170]
95% CI: 95% conﬁdence interval; ACS: acute coronary syndrome.
a Number of subjects in each category.
b Adjusted for centre, age, gender and previous medical treatments.
c Adjusted for centre, age, gender and previous medical treatments, type of ACS and hospitalization before ACS occurrence.
d Adjusted for centre, age, gender and previous medical treatments, type of ACS, out-of-hospital and in-hospital life-and-death emer-
gency, acute heart failure, delay until hospitalization and hospitalization before ACS occurrence, transfer with a medical mobile unit,
out-of-hospital use of speciﬁc treatments and thrombolytic drugs, in-hospital recommended treatments.
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besuscitated  cardiac  arrests  (79.8%)  and  several  shocks.  Out-
f-hospital  management  was  faster  and  more  medicalized
n  the  case  of  life-and-death  emergency,  but  patients  were
ess  likely  to  receive  speciﬁc  treatments  or  undergo  coronary
xploration  or  revascularization.
Subjects  already  hospitalized  before  the  ACS  event
ere  older,  more  frequently  women  and  presented  more
ften  with  co-morbidities.  The  type  of  ACS  was  more  fre-
uently  unclassiﬁable  and  patients  seldom  received  speciﬁc
reatments  and  revascularization  (25.8%),  thus  indicating
omplicated  clinical  situations  in  patients  with  multiple
iseases.  Patients  with  very  low  rates  of  exploration  and
evascularization  are  likely  to  have  a  poor  initial  prognosis.
ndeed,  these  patients  were  also  those  presenting  more  fre-
uently  with  acute  heart  failure,  resuscitated  cardiac  arrest
nd  overall  shocks,  and  had  a  high  rate  of  early  death  (51.8%
n  the  ﬁrst  24  hours  and  78.6%  in  the  ﬁrst  28  days).
Patients  who  did  not  have  coronary  angiography  were  also
lder,  more  frequently  women,  more  prone  to  be  receiving
hronic  treatments  and  to  have  unclassiﬁable  ACS  compared
o  those  who  did  have  angiography.  Rates  of  complications
ere  also  higher  among  these  patients;  although  they  were
anaged  faster  and  were  more  medicalized,  they  had
ery  low  rates  of  out-of-hospital  and  in-hospital  treatments
L
T
f9.6%).  Shorter  delays  to  hospitalization  and  high  rates  of
ut-of-hospital  medicalization  are  in  accordance  with  a
evere  initial  presentation.  These  patients  appeared  to  have
 very  poor  initial  prognosis,  with  treatments  and  revascu-
arization  of  no  beneﬁt  as  most  of  them  died  during  the  acute
hase  of  the  event  (52.9%  in  the  ﬁrst  24  hours  and  84.9%  in
he  ﬁrst  28  days).  The  lack  of  coronary  angiography  was  not
nterpreted  as  a  variable  of  management,  but  as  a  proxy
ariable  of  initial  severity  of  presentation.  This  perception
as  strengthened  by  the  fact  that  there  was  no  difference
n  outcome  among  patients  who  had  a  coronary  angiography
lone  and  those  who  had  angiography  with  PCI.
Finally,  these  three  selected  variables  were  interpreted
s  proxy  variables  corresponding  to  the  same  negative
rognosis.  Indeed,  they  probably  corresponded  to  a  poor
rognosis  even  before  the  subjects  received  treatments  for
CS,  and  despite  rapid  management,  and  were  not  modiﬁed
y  classic  acute  care.imitations
his  study  is  based  on  observational  data  and  is  there-
ore  subject  to  potential  confounding.  For  example,  the
One-year  prognosis  and  severity  of  ACS  in  France  
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RFigure 3. Distribution of 28-day and 1-year mortality among the
2547 incident ACS. ACS: acute coronary syndrome.
effect  of  bias  is  clear  in  relation  to  delays  to  hospital-
ization,  as  we  observed  increased  mortality  with  shorter
delays.  Similarly,  variables  related  to  the  management  of
the  acute  event  should  be  interpreted  with  caution  despite
extensive  adjustment  for  the  severity  of  the  event.  Our
analyses  also  suffer  from  a  lack  of  information  on  renal  func-
tion  and  co-morbidities  given  that  recommended  treatments
may  have  been  avoided  because  of  contraindications  linked
to  the  patient’s  medical  history.  Several  factors  were  not
collected,  such  as  renal  insufﬁciency,  peripheral  artery  dis-
ease  or  cancer,  which  are  important  predictors  of  mortality.
There  were  also  insufﬁcient  data  on  delays  to  reperfusion,
which  is  a  signiﬁcant  predictor  of  death  in  STEMI.  However,
we  evaluated  the  initial  management  through  delays  to  hos-
pitalization.  Concerning  missing  data,  they  were  generally
limited  (1—3%)  and  were  analysed  as  a  speciﬁc  category
when  they  were  more  frequent.  Sensitivity  analyses  for  miss-
ing  data  did  not  show  any  signiﬁcant  differences  in  the
results.
Conclusions
Despite  a  1-year  follow-up,  the  majority  of  deaths  recorded
occurred  during  the  out-of-hospital  period  (70.3%),  or  in  the
days  following  hospitalization  (34.4%  in  the  ﬁrst  24  hours,
71.5%  in  the  ﬁrst  28  days  in  patients  who  reached  the  hos-
pital  alive).  Moreover,  almost  60%  of  out-of-hospital  phase
survivors  who  died  during  1-year  follow-up  were  attributable
to  three  situations,  corresponding  to  patients  with  a  very
high  mortality  (72.8%  of  attributable  deaths  after  analysis  of
28-day  mortality).  These  situations  were  characterized  by  an
initial  severe  clinical  presentation  and  very  low  rates  of  use
of  speciﬁc  treatments  and  invasive  procedures.  It  seems  that
the  prognosis  for  these  patients  was  already  compromised
at  the  initial  phase  because  of  irreversible  damage,  making
any  intervention  inefﬁcient.  These  situations  are  very  close
to  out-of-hospital  deaths  on  these  points  and  the  combina-
tion  of  both  (out-of-hospital  and  attributable)  corresponded
to  87.8%  of  deaths  after  1  year  of  follow-up  and  to  93.7%  of
deaths  after  28  days  (Fig.  3).
Reducing  further  the  case-fatality  of  ACS  appears  to  be
very  difﬁcult  despite  the  availability  of  new  treatments;
current  therapies  are  already  very  efﬁcient,  and  further487
mprovements  appear  to  beneﬁt  only  those  who  have  a  low
robability  of  dying.  After  the  exclusion  of  out-of-hospital
eaths  and  deaths  attributable  to  the  three  situations
escribed  above,  1-year  case-fatality  would  have  decreased
rom  29.3%  to  4.8%,  which  is  close  to  the  rate  described  in
urrent  randomized  trials.
Our  results  highlight  the  importance  of  prevention  in
ecreasing  the  incidence—and  consequently  mortality—of
CS,  given  that  case-fatality  seems  difﬁcult  to  reduce.
ducating  the  general  public  about  cardiac  arrest  and
he  importance  of  early  management  and  prevention  (e.g.
rompt  medical  contact  in  case  of  suspected  chest  pain,
elephoning  the  emergency  services  in  the  case  of  suspected
ardiac  arrest,  and  primary  management  of  cardiac  arrest),
nd  making  available  semiautomatic  deﬁbrillators  in  public
laces,  are  measures  that  have  been  promoted  in  France  and
lsewhere  in  order  to  decrease  case-fatality  related  to  ACS,
ut  these  measures  still  have  limitations.  Indeed,  more  than
4%  of  out-of-hospital  deaths  occur  at  home.  Furthermore,
ut-of-hospital  deaths  often  occur  in  relatively  young  peo-
le  who  have  no  prior  alerting  symptoms,  making  potential
ictims  difﬁcult  to  identify.
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